Methamphetamine-associated cardiomyopathy: Patterns and predictors of recovery

Internal Medicine Journal

Volumn 46, Issue 6, 2016, Pages 723-727

  Voskoboinik, A ^a   Ihle, J F ^a   Bloom, J E ^a   Kaye, D M ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cardiomyopathy; Heart failure; Methamphetamine; Reverse Takotsubo

Indexed keywords

HEART ENZYME; INOTROPIC AGENT; METHAMPHETAMINE;

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HUMAN; HYPOKINESIA; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC DYSFUNCTION; TAKOTSUBO CARDIOMYOPATHY; TRANSTHORACIC ECHOCARDIOGRAPHY; CARDIAC MUSCLE; CHEMICALLY INDUCED; COMPLICATION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HEART STROKE VOLUME; HEART VENTRICLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; VICTORIA;

ADULT; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE; MYOCARDIUM; RETROSPECTIVE STUDIES; STROKE VOLUME; TAKOTSUBO CARDIOMYOPATHY; VICTORIA;

EID: 84971408183     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.13050     Document Type: Article

References (20)

1. Australian Institute of Health and Welfare. National Drug Strategy Household Survey Detailed Report: 2013. Drug statistics series no. 28. Canberra: AIHW; 2014.
2. Stokes MB, Fernando H, Taylor AJ . Cardiogenic shock secondary to methamphetamine induced cardiomyopathy requiring veno-arterial extra corporeal membrane oxygenation. Int J Cardiol 2016; 207: 134-5.
3. Won S, Hong RA, Shohet RV, Seto TB, Parikh NI . Methamphetamine-associated cardiomyopathy. Clin Cardiol 2013; 36: 737.
4. Diercks DB, Fonarow GC, Kirk JD, Jois-Bilowich P, Hollander JE, Weber JE et al. ADHERE Scientific Advisory Committee and Investigators. Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module). Am J Cardiol 2008; 102: 1216-19.
5. Yeo KK, Wijetunga M, Ito H, Efird JT, Tay K, Seto TB et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med 2007; 120: 165-71.
6. Rajs J, Falconer B . Cardiac lesions in intravenous drug addicts. Forensic Sci Int 1979; 13: 193-209.
7. Kaye S, McKetin R, National Drug and Alcohol Research Centre (Australia). Cardiotoxicity Associated With Methamphetamine Use and Signs of Cardiovascular Pathology Among Methamphetamine Users. Sydney: NDARC; 2005.
8. Lord KC, Shenouda SK, McIlwain E, Charalampidis D, Lucchesi PA, Varner KJ . Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovasc Res 2010; 87: 111-18.
9. Seiden LS, Sabol KE . Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr 1996; 163: 251-76.
10. Kalant H, Kalant OJ . Death in amphetamine users: causes and rates. Can Med Assoc J 1975; 112: 299-304.
11. Maeno Y, Iwasa M, Inoue H, Koyama H, Matoba R . Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes. Int J Legal Med 2000; 113: 201-7.
12. Islam MN, Kuroki H, Hongcheng B, Ogura Y, Kawaguchi N, Onishi S et al. Cardiac lesions and their reversibility after long term administration of methamphetamine. Forensic Sci Int 1995; 75: 29-43.
13. He SY, Matoba R, Fujitani N, Sodesaki K, Onishi S . Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol 1996; 17: 155-62.
14. Lopez JE, Yeo K, Caputo G, Buonocore M, Schaefer S . Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2009; 11: 46.
15. Kiel RG, Ambrose J, Khatri B, Bhullar M, Nalbandyan M, Ronaghi R . The prevalence and presentation of methamphetamine associated cardiomyopathy: a single center experience. J Am Coll Cardiol 2015; 65: A942.
16. Ito H, Yeo KK, Wijetunga M et al. A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse. Clin Cardiol 2009; 32: E18-22.
17. Reuss CS, Lester SJ, Hurst RT . Isolated left ventricular basal ballooning phenotype of transient cardiomyopathy in young women. Am J Cardiol 2007; 99: 1451.
18. Hurst RT, Prasad A, Askew JW, Sengupta PP, Tajik AJ . Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging 2010; 3: 641-9.
19. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 2015; 373: 929-38.
20. Tranter MH, Wright PT, Sikkel MB, Lyon AR . Takotsubo cardiomyopathy: the pathophysiology. Heart Fail Clin 2013; 9: 187-96.